Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR(®) TS

AIMS: This study assessed the cost efficacy and cost utility of the automatic blood glucose meter CONTOUR(®) TS from the public payer (National Health Fund [NHF]) and payer (patient and NHF) perspectives over a 26-year analysis horizon. METHODS: Clinical effectiveness data were obtained from prior c...

Descripción completa

Detalles Bibliográficos
Autores principales: Holko, Przemyslaw, Kawalec, Pawal
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064416/
https://www.ncbi.nlm.nih.gov/pubmed/21448325
http://dx.doi.org/10.2147/DMSO.S9395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064416/
https://www.ncbi.nlm.nih.gov/pubmed/21448325
http://dx.doi.org/10.2147/DMSO.S9395

Ejemplares similares